Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 159
2
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Working towards a low-cost ostomy bag that doesn't leak

Ostomy bags are a daily medical necessity for 15 million people globally. However, these bags often delaminate...

Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection

We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...

How does Sprint Training Impact Blood Sugar and Inflammation?

Exercise intensity has a huge effect on how endurance training, like running, effects health. While research...

Backer Badge Funded